2015 CTRC-AACR San Antonio Breast Cancer Symposium *

December 8-12, 2015; San Antonio, Texas
This program provides coverage of 2015 San Antonio Breast Cancer Symposium with downloadable slidesets and expert analysis of the most clinically relevant study results. Topics include the treatment of early and metastatic breast cancer, predictive biomarkers, and managing adverse events.

Share

Program Content

Activities

JAVELIN: Avelumab in MBC
JAVELIN Solid Tumor Trial: Avelumab in Locally Advanced or Metastatic Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2015

Expires: December 08, 2016

Dual Anti-HER2 Tx in LA Breast Cancer
NSABP FB-7: Dual HER2-Targeted Therapy in HER2+ Locally Advanced Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2015

Expires: December 11, 2016

Denosumab in HR+ BC
ABCSG-18: Effect of Adjuvant Denosumab on DFS in Postmenopausal Women With Early HR+ Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2015

Expires: December 11, 2016

TH3RESA Final OS Results
TH3RESA Final Results: T-DM1 vs Physician’s Choice for HER2+ MBC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2015

Expires: December 12, 2016

PALOMA-3: Palbociclib in MBC
Fulvestrant ± Palbociclib in ER+/HER2- Breast Cancer: An Extended Follow-up of PALOMA-3
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2015

Expires: December 12, 2016

ExteNET: Neratinib in HER2+
ExteNET: DFS With Neratinib in HER2+ BC After Adjuvant Trastuzumab
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2015

Expires: December 12, 2016

Pembrolizumab in ER+/HER2- BC
KEYNOTE-028: Pembrolizumab in PD-L1+, ER+/HER2- Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2015

Expires: December 13, 2016

T-DM1 vs Trastuzumab in EBC
WSG-ADAPT: Trastuzumab Emtansine ± ET vs Trastuzumab + ET in HER2+/HR+ Early Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2015

Expires: December 13, 2016

CREATE-X: Capecitabine in HER2- EBC
CREATE-X: Adjuvant Capecitabine in HER2-Negative Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2015

Expires: December 13, 2016

Neoadjuvant Palbociclib in ER+/HER2- BC
Neoadjuvant Palbociclib + Anastrozole in ER+/HER2- Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2015

Expires: December 14, 2016

Neoadjuvant Carboplatin in Early BC
GeparSixto: Neoadjuvant Chemotherapy ± Carboplatin in Patients With HER2-Positive or Triple-Negative Early Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2015

Expires: December 14, 2016

Buparlisib in HR+/HER2- MBC
BELLE-2: Fulvestrant ± Buparlisib in HR+/HER2- Advanced Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2015

Expires: December 14, 2016

Albumin-Bound Paclitaxel Regimens in TNBC
WSG-ADAPT TN: Neoadjuvant Albumin-Bound Paclitaxel + Carboplatin or Gemcitabine in TNBC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 17, 2015

Expires: December 15, 2016

BCIRG 006: 10-Yr Follow-up
BCIRG 006: 10-Yr Follow-up of Adjuvant AC → T Compared With AC → TH and TCH for HER2+ Early BC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2015

Expires: December 16, 2016

Abemaciclib Combinations in MBC
Abemaciclib + Endocrine or HER2-Targeted Therapies in Metastatic Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2015

Expires: December 16, 2016

Downloadable Slideset
New Developments in Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 11, 2016

Expires: January 09, 2017

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Genentech BioOncology

Novartis Pharmaceuticals Corporation

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.